Yale University

EliScholar – A Digital Platform for Scholarly Publishing at Yale
Yale Medicine Thesis Digital Library

School of Medicine

1967

Amniotic fluid bilirubin measurement: a
comparison of five methods
Jonathan Savell
Yale University

Follow this and additional works at: http://elischolar.library.yale.edu/ymtdl
Recommended Citation
Savell, Jonathan, "Amniotic fluid bilirubin measurement: a comparison of five methods" (1967). Yale Medicine Thesis Digital Library.
3130.
http://elischolar.library.yale.edu/ymtdl/3130

This Open Access Thesis is brought to you for free and open access by the School of Medicine at EliScholar – A Digital Platform for Scholarly
Publishing at Yale. It has been accepted for inclusion in Yale Medicine Thesis Digital Library by an authorized administrator of EliScholar – A Digital
Platform for Scholarly Publishing at Yale. For more information, please contact elischolar@yale.edu.

YALE UNIVERSITY LIBRARY

3 9002 06679 1832

' ■ '

'•

;• -l■;•

•• '

;

•;

•<;* $** • 'r‘

■ ■

■

' :

YALE

MEDICAL LIBRARY

\

AMNIOTIC FLUID BILIRUBIN MEASUREMENT:
A COMPARISON OF FIVE METHODS

Jonathan Saveli
A.B. Columbia College, 1963

A Thesis Presented to the
Faculty of the School of Medicine
Yale University
in Partial Fulfillment of the
Requirements for the Degree of
Doctor of Medicine

Department of Obstetrics and Gynecology
Yale University, New Haven, Connecticut
April, 1967

p
<

A?

Acknowledgements

I would like to express my gratitude
Dr.

Maclyn E. Wade, my thesis

for the help

given me by

advisor, whose clinical and research

achievements have been an inspiration to me.
For her help in drawing graphs,
grateful thanks

go to my wife,

and typing this thesis, my

Cynthia.

Digitized by the Internet Archive
in 2017 with funding from
The National Endowment for the Humanities and the Arcadia Fund

https://archive.org/details/amnioticfluidbilOOsave

Table of Contents

Pages
I.

Introduction

II.

Method

2 -

8

III.

Results

9 -

10

IV.

Dis cussion

11 - 19

V.

Bibliography

20 - 21

1

1
Introduction
Since Bevls

(1)

first showed a correlation between the severity

of hemolytic disease of the newborn and the amounts of several sub¬
stances present in the amniotic fluid,

amniocentesis has been wide¬

ly used as a diagnostic aid in this disease.

Liley

(13,

14)

showed

that the most important of these substances was bilirubin, which he
measured using a direct spectrophotometric method.

Results were ex¬

pressed in optical density units.
'Although most workers since
method,

others have

niotic fluid.
(22),

purpose.

attempted to quantitate bilirubin levels

Robertson

and Freda (8)

then have been satisfied with Liley’s

(19),

Bower and Swale

(2), Watson and Mackey

used various diazotization techniques

for this

Fleming and Woolf devised another direct spectrophotometric

method, which unlike Liley’s was quantitated to give
per cent

in am¬

of bilirubin

(5).

This paper will compare several of these methods
bilirubin,

results in mg.

in terms of accuracy,

for measuring

reproducibility and convenience.

.

2

Method

131

After localization of the placenta with radioactive
albumin,

I

labeled

amniotic fluid was obtained by transabdominal percutaneous

puncture with a 20

gauge spinal needle.

Ten to fifteen cc.

of amniotic

fluid was withdrawn and centrifuged for 30 minutes at 3000 rpm.
cloudy,

it was then filtered through Whatman No.

If still

1 paper with suction.

Method I:
The AO.D.
of

(Liley) was determined by measuring the optical density

the amniotic fluid against distilled water from 365 my to 700 my in

a continuous

recording Perkin-Elmer 202 Spectrophotometer using

path length cells
my
my

(13).

The tangent

to the

and 550 my was drawn and height of the

1

cm.

curve at approximately 365
curve

from the tangent

at 450

was expressed in optical density units.

Method II:
Bilirubin was measured by the method of Fleming and Woolf
the

following manner.

Using distilled water as

of the amniotic fluid was measured in
623 my

,

576 my,

using the

found that

Bilirubin,

Bilirubin =
B ~ O.D.

path length cells

repeating the reading at

readings

at

700 my ,

at

and therefore this

in mg./100 ml., was

1.25D - 0.91C -

at 623 my,

this wavelength.

of sodium
700 my,

This

and

author,

addition of sodium dithionite invariably in¬

creases the absorbance at 700 my ,
added.

the absorbance

addition of a few crystals

amniotic fluid,

lower of the two

however, has

in

and 462 myin the Zeiss PM QII/M4 Oil Spectrophotometer.

Fleming and Woolf described the
dithionite to the

1 cm.

a blank,

(5)

C = O.D.

chemical was not

calculated using the

1.15B + 0.11A, where A = O.D.
at 576 my,

and D = O.D.

formula:
at

700 my,

at 462 my.
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Method III:
Bilirubin was

then measured by the method of Robertson

(19).

Reagents:
(1)

Diazo A:

Sulfanilic acid,

1 gm.

in

1000 ml.

of hydro¬

chloric acid solution prepared by mixing 15 ml.
concentrated HC1 with water to make
Diazo B:
0.1 ml.

of 50% stock solution of sodium nitrite to

9.9 ml.

of water.

is kept

refrigerated.

of solution A.

The sodium nitrite stock solution

Add 0.3 ml.
Make

of solution B

to

10 ml.

fresh daily.

Hydrochloric acid solution:
HC1 to water to make

(3)

1000 ml.

Sodium nitrite 0.5%, made fresh daily by adding

Diazo solution:

(2)

of

Mix 15 ml.

of concentrated

1000 ml.

Methanol

Method:
The following solutions were prepared:
(A)

2 ml.

amniotic fluid,

1 ml.

diazo solution,

and 3 ml.

HC1 solution.
(B)

2 ml.

amniotic fluid and 4 ml.

(C)

2 ml.

amniotic fluid,

1 ml.

HC1 solution.

diazo solution,

and 3 ml.

methanol.
(D)

2ml.

amniotic fluid,

3 ml.

methanol,

and 1 ml. HC1

solution.
All solutions were allowed to stand for 10 minutes.
B was

read against A to determine direct bilirubin,

C to determine total bilirubin.

Solution

and D against

4

All optical density measurements were made in

1 cm.

path length

cuvettes at 530 mp in the Zeiss PM QII/M4 Spectrophotometer.
Robertson did not describe preparation of standards, but they can
be prepared by adding commercial bilirubin in chloroform solution
to methanol and substituting for methanol in solutions C and D.
Method IV:
Bilirubin was

then measured by the method of Bower and Swale

(2) .

Reagents:
(1)

Diazo reagent:
1000 ml.

Solution A:

of 0.175 N HC1.

nitrite, prepared as
Ten ml.

1 gm.

sulfanilic acid in

Solution B:

described above.

of A was mixed with 0.3 ml.

5 minutes

1 ml.

0.5% sodium

of 1.5%

of B.

After

ammonium sulfamate was

added,

and the reagent was used after standing for at

least

3 minutes.
Blank reagent was made by substituting distilled water
for solution B in the diazo reagent.
(2)

Ethanol-urea solution:
in

100 ml.

of 85%

solution was

(v/v)

25

gm.

of urea was dissolved

ethanol by heating.

The

filtered through glass wool while still

warm and kept in an incubator to prevent

crystallization

of urea.
(3)

Sodium azide, powder.

(4)

Phenol,

liquid,

88%

(Mallinkrodt).

(5)

Neutral buffer:

5.0

gm.

of sodium citrate was

in distilled water and made up to

100 ml.

dissolved

5

(6)

Acid buffer:

11.8 gm.

of sodium citrate was

in 0.2 N HC1 to a volume of 200 ml.

dissolved

and this was made

up to 500 ml. with distilled water.
(7)

Chloroform

Method:
Amniotic fluid,
tubes.

To the

second,

0.5 ml.

0.5 ml., was put in each of two 10 ml.

first was added 0.5 ml.
of blank reagent.

containing ice-colled water.
chloroform was added,

of diazo reagent,

test

and to the

Both tubes were placed in a beaker

Ethanol-urea,

2.2 ml.,

and 0.2 ml.

of

and the tubes were mixed and allowed to stand

in the ice water for 10 minutes.

After removal from the ice,

a tiny

fragment of sodium azide was added to each tube and dissolved by shak¬
ing.

Neutral buffer, 0.1 ml., was

added followed by mixing.

2.5 ml., was added by burette into each tube
ously mixed with a Vortex-Genie mixer.
against the blank at 530 my in 3 cm.

Phenol,

and the tubes were vigor¬

The diazo mixture was

read

path length cuvettes using the

Zeiss PM Q11/M4 Qll Spectrophotometer.
Standards were prepared from bilirubin 1 mg./ml.
(Fisher).
form,

in chloroform

This was used in the reaction mixture in place of chloro¬

and acid buffer was used instead of amniotic fluid.

dilutions

Appropriate

of the bilirubin standard were made in chloroform to give

bilirubin concentrations equivalent
mg./lOO ml.

to 2.0,

1.0,

0.5, 0.25,

and 0.125

in amniotic fluid.

Method V:
Bilirubin was

then measured by

described by Gambino (9) .

the Jendrassik-Grof method as

Proportions

of the reagents have been changed

to make the resulting color more intense.

'

'

:

6

Reagents:
(1)

Caffeine mixture: 50 gm.
benzoate,

and 125

gm.

of caffeine,

75

of sodium acetate

gin.

of sodium

(-SH^O) were

added to distilled water at 50-60°C.,

and the volume

was brought up to 1000 ml.

It was

when cool.

then fil¬

tered through glass wool.
(2)

Diazo A: 5.0 gm.

sulfanilic acid and 15.0 ml.

of concen¬

trated hydrochloric acid were added together and the vol¬
ume brought up

to 1000 ml.

It was then filtered through

glass wool.
Diazo B:

0.5% sodium nitrite solution was prepared as

described above.
Diazo reagent was prepared by mixing 10.0 ml.
with 0.25 ml.

of Diazo B.

of Diazo/A

Diazo reagent was made

fresh

daily.
(3)

Alkali mixture:

100 gm.

of sodium hydroxide and 350 gm.

of potassium sodium tartrate were dissolved in distilled
water and the volume brought up

to 1000 ml.

It was

fil¬

tered through glass wool.
Method:
Caffeine mixture,
unknown and blank.

1.0 ml., was

To each tube was

After the addition of 0.17 ml.
and 0.17 ml.

added 0.5 ml.

labeled

of amniotic fluid.

of Diazo reagent to the unknown tube

of Diazo A to the blank, both tubes were mixed and al¬

lowed to stand for 10 minutes,
was

added to each of 2 tubes,

added and the tubes

after which 0.5 ml.

again shaken.

of alkali mixture

Within 30 minutes,

the optical

.
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density of the unknown was measured against the blank, using 1 cm.
light path cuvettes in the Zeiss PM QII/M4 Oil spectrophotometer.
Standards were prepared as follows.

Bilirubin powder, 20 mg.,

(Eastman) was weighed to within 0.1 mg. in a tiny aluminum foil "boat'
which was then pushed to the bottom of a 100 ml. volumetric flask so
that all the bilirubin was deposited at the bottom of the flask.

In

subdued light 4 ml. of 0.1 N NaOH was added and the bilirubin dissolved
by swirling.

Fifty ml.

of 1.5 gm. per cent human serum albumin in

normal saline, prepared from pooled concentrated human serum albumin
(American National Red Cross) , was then added and the contents of the
flask again swirled.

Four ml.

of 0.1 N HC1 was added to neutralize the

alkali, and 1.5% albumin was added to bring the volume up to 1000ml.
Using the albumin solution and saline, solutions of 2.0, 1.0, 0.5,
0.25, and 0.10 mg. per cent bilirubin in 0.75 gm. per cent albumin
were prepared and subjected to diazotization in the same manner as
amniotic fluid.
The following tests were performed on amniotic fluid samples:
AO.D.

(Liley)

all samples

Bilirubin (Fleming - Woolf)

85 samples

Bilirubin (Bower - Swale)

58 samples

Bilirubin (Robertson)

20 samples

Bilirubin (Jendrassik - Grof)

51 samples

The values obtained by each method were plotted as the abcissa
versus the corresponding AO.D.

(Liley) values as ordinates.

The best

straight line was drawn through these points as calculated by the fol¬
lowing formula:

8

Equation of line is

Y = a + 8X

where

_ EYEX2 - EXEXY
“ ~ NEX2

-

(EX)2

NEXY - EXEY
3 -~NEXZ The

coefficient

(EX)z

of correlation

(r) was

calculated as

follows:

NEXY - EXEY
r

=

—

■ - ■■

-

/ {NEXZ -

(EX)z}

{NEYZ -

The standard error of estimate is

(EY)2}

found by the

following calcu¬

lation :

(qEY + 3EXY)

s

N

The standard deviation of repeated measurements made

on the same sam-

r^2
pie is:

a =/ —, where x is

the deviation of each measurement

from

the mean and N is the number of samples.
For the Jendrassik-Grof method the molar absorptivity of alk¬
aline azobilirubin was
24

Where
M.W.
cm.

^ GOO™!-1 _
‘1cm.

M.A.^^mh =

calculated from this equation:

M.W. • A/cm. • final volume in ml.
Total amount of bilirubin in mg.
Molar absorptivity at 600 my for 1 cm.

= Molecular weight of bilirubin

(584),

A/cm.

light path,

= Absorptivity per

of light path.
As suggested by Gambino (9),

and not

the molecular weight of bilirubin

azobilirubin is used in the calculation.

9

Results

The results are summarized in Table

Table

Method:

all

versus AO.D.
(Liley)

1

1

Equation of

Coefficient Standard

best straight

of
error of
correlation estimate

line

(Optical
density

Standard deviation
of repeated
measurements on a
single sample
(mg.% bilirubin)

units)

Bower-Swale

Fleming-Woolf

AO.D.*
0.014+0.66Bili

0.94

0.046

0.043

AO.D.=

0.96

0.034

0.01

0.99

0.024

0.021

-0.016+0.59Bili
Jendrassik-Grof

AO.D.*
-0.025+0.74Bili

Robertson

,_

Unusable
(See

__

_

text)

Bilirubin was measured by the Fleming-Woolf method in 85
samples

and the comparison between these values

(Liley)

is shown in Figure

and the AO.D.

1.

The Bower-Swale method was used to measure bilirubin in
58 samples,

and the plot against

AO.D.

is shown in Figure 2.

The

standardization curve for the Bower-Swale method is shown in Figure
Bilirubin in 51 samples was measured using the JendrassikGrof method and the results

are plotted against AO.D.

The standardization curve is shown in Figure 5.
sorptivity of azobilirubin is

in Figure 4.

The molar ab¬

calculated to be 72,500.

In all graphs the dashed lines

represent

±1 standard error of

3.

s

*
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estimate.
Robertson's method for measuring total bilirubin gave solutions
with such a great amount
the spectrophotometer,

of turbidity

that they could not be

and therefore it

could not be used.

ect bilirubin was negligible in the 20 samples tested,
the indirect and total bilirubin were nearly equal.

read in
The dir¬

and therefore

'

(ash n) a

o ^7

.

AOD (LI LEY)

0.5

o.i

'

(A3in) aoy
.2.

I.'

.3

BILIRUBIN (mcj./ioo ml.) JENDRASSIK— GROF)
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Discussion

Liley's

AO.D.

method for measuring amniotic fluid bilirubin was

the first to be suggested,

and it became immediately popular.

direct spectrophotometric method, no reagents were required.
a continuous

Being a
Although

recording spectrophotometer is not absolutely necessary,

with a manual instrument readings must be made at twelve individual
wavelengths.
wavelength,

Not only must the spectrophotometer be
it must be

linear at every

absolutely accurate at every wavelength.

Be¬

cause there is no standardization with known bilirubin samples,

re¬

sults must be expressed in "optical density units"

and workers using

two different spectrophotometers have no way of knowing whether their
results

are in agreement.

Walker,

Fairweather and Jones

(21)

used a direct spectrophoto¬

metric method similar to Liley's except that per cent transmission
instead of optical density was plotted against wavelength.
from the

tangent to the

pressed as

curve itself at 450 my was measured and ex¬

a difference in per cent

this method is

The distance

that it is

transmission.

The disadvantage

optical density, not per cent

which is proportional to the

amount

per cent transmission is used,

of pigment present,

transmission,
so that when

the presence of varying amounts

turbidity in the amniotic fluid will change

the estimate

of

of

of bilirubin

present.
Fleming and Woolf quantitated a direct spectrophotometric method
for measuring bilirubin

(5).

They found that the

four factors which

contributed to the optical density of amniotic fluid were bilirubin,
turbidity,

and oxyhemoglobin and methemalbumin if present.

By per-

-
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forming spectrophotometric scans
it was possible
each of them.

on these components

to find the wavelengths

The optical densities

at each of four wavelengths,

one

method,

the bilirubin was

form,

of greatest absorption for

of the

four substances were

for each component,

lation between these and the knowledge
substance,

in pure

found

and from the

re¬

of the absorbance of each pure

calculated.

As with the AO.D.

(Liley)

the spectrophotometer must be absolutely accurate at the

four

wavelengths used.
Other workers have used diazo reactions
bilirubin,

for quantitating

although some have questioned their use.

Liley believed

that accuracy would be decreased by dilutional errors
deterioration of reagents

(13).

Freda

(7)

and by

stated that chemical

tests

for amniotic fluid bilirubin were undesirable, since he believed that
bilirubin was just one
breakdown,

of many similar pigments

from hemoglobin

all of which absorb between 400 my and 500 my,

fore concluded that the

and there¬

AO.D. was a more accurate indication of the

fetal status.
Using reverse phase Kieselguhr column chromatography, however,
Brazie et

al.

demonstrated that

bilirubin, so that

this objection has been overcome

The diazo methods
methods in use

for serum,

levels

protein levels
reagents

(3).

that have been employed are adaptations

of

often with a greater proportion of amniotic

fluid in the reaction mixture
significant

the pigment in amniotic fluid is only

to intensify the final color.

of bilirubin are often as

are often greater than

1 gm.

low as 0.1 mg.
per cent

(4) ,

that precipitate proteins may cause significant

Although
per cent,

and coupling
turbidity

-

n:
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preventing the measurement of the bilirubin present.
Robertson

(19),

and Watson et

al.

(22)

used a modified Malloy-

Evelyn method employing as a coupling agent methanol, which pre¬
cipitates protein.

Robertson also measured the direct bilirubin by

omitting the coupling reagent,
the
more

total bilirubin,
accurate

and by subtracting the direct

from

obtained the indirect which he believed was

that the AO.D.

in predicting fetal outcome.

four poorly defined categories of

fetal outcome were used,

of a total of 252 predictions based on the aO.D.,

Only
and out

of which 193 were

correct and 59 incorrect, 23 could be corrected by considering only
the indirect bilirubin.
predictions based on

It was not noted, however, how many correct

the aO.D. would be "uncorrected" by considering

the indirect bilirubin,

and therefore the two methods were not com¬

pared in a meaningful manner.
Michaelsson

(16),

using the Malloy-Evelyn method on serum,

that turbidity of the blank solution varied from time
sample to sample.

Other disadvantages

are the

long period,

30 minutes,

and the

low sensitivity.

found

to time and from

of the Malloy-Evelyn technique

required for complete diazotization

Because of the low bilirubin level in amnio-

tic fluid compared to serum,

the disadvantages of the Malloy-Evelyn

method should be even more serious when applied to amniotic fluid meas¬
urements .
Robertson did not mention problems
reaction mixtures

caused by turbidity of the

containing methanol, but this writer has

the diazo and blank tubes

found that

often have different degrees of turbidity,

making it impossible to ascribe

the difference in optical density bet-

■

V
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ween the two tubes
rubin present.
times

as

these

reasons

as being related in any way to the amount

Often the optical density due

great

as

that estimated to be

of bili¬

to turbidity was

ten

caused by the bilirubin.

diazotization with methanol was

For

found to be totally

unsatisfactory.
Bower and Swale employed the diazo method of Patterson,
and Maggs

(17),

in which coupling is effected by ethanol-urea sol¬

ution which precipitates protein,
activated by sodium azide,
redissolved with phenol.
but the

excess diazo reagent is

then in¬

and finally the precipitated protein is
The

resulting solutions

are optically clear,

concentrations of ethanol and phenol required are quite large,

necessitating a 1:12
solution to be

dilution of the amniotic fluid before

read in the spectrophotometer is obtained;

the sensitivity of the method is

low.

itives were

the

consequently,

or "negative,"

and all pos¬

listed as having bilirubin greater than 0.12 mg.

implying that

final

Bower and Swale expressed results

for the assay of bilirubin as "positive"

per cent,

levels below this value could not be accurately determined.

This writer has confirmed this
ments on the same sample
est of all methods

gave

lack of accuracy.

Repeated measure¬

a standard deviation of 0.043,

tested with the exception of Robertson’s.

the difficulties was

the

the high¬
One of

lack of miscibility of phenol and the ethanol-

water solutions, even after vigorous
er.

Swale

When placed in the cuvette,

agitation using a mechanical mix¬

striations would form in the sol¬

ution which would not

respond to all attempts

at

removing them,

from

stirring with a glass

rod to blowing fine bubbles through the solution

■
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with a Pasteur pipette.
measurements

Once striations

on the solution were not

formed, optical density-

repeatable.

Jendrassik and Grof developed a diazo method making use of a
caffeine-sodium benzoate
protein

(12).

coupling reagent that

After diazotization,

to alkaline pH, producing a blue
bilirubin than

did not precipitate

the reaction mixture was brought

color which was more specific for

the pink azobilirubin

formed at acid pH.

Fog (6)

found that the protein concentration of the sample did not

affect

the degree of diazotization within a fiftyfold dilution of serum.
Duplicate determinations
mean difference of less

on 43 different serum samples showed a
than

1%.

The green color of

the

final

reaction mixture was noted to be a combination of blue alkaline
azobilirubin and the yellow color formed by the
reagent with caffeine at

alkaline pH.

absorbed a negligible amount

reaction of diazo

At 600 my this yellow pigment

of light,

and therefore did not inter¬

fere with the bilirubin determination even in weak solutions.
Michaelsson found that hemoglobin in concentrations up
per cent inhibited diazotization to

cause an apparent

to 280 mg.
loss in

measured bilirubin of only 2%, which increased to 8% at a hemoglobin
concentration of

1400 mg.

per cent

(16).

The addition of ascorbic

acid to the diazotization reaction mixture prevented inhibition by
hemoglobin.
Gambino and Freda adapted the Jendrassik-Grof method to the
measurement of bilirubin in amniotic fluid
the best straight line
AO.D.

comparing

= -0.011 + 0.74 Bilirubin.

for that plot was 0.99,

AO.D.

(10).

The equation of

and bilirubin was

The coefficient of correlation

and the molar absorptivity of azobilirubin

! C ‘.

7

.
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was 72,500, within 0.7% of that found by them.

The equation of the

best straight line was AO.D. = -0.025 + 0.74 Bilirubin.

The slopes

determined by this writer and Gambino are the same, 0.74, and the
AO.D. intercepts differ by 0.014 optical density units, so that the
AO.D.

as determined by this writer is uniformly 0.01 optical den¬

sity unit lower than that determined by Gambino, an insignificant
difference practically.
In addition to using different coupling agents, the three
diazo methods tested here employ three different types of standards.
The Bower-Swale, Malloy-Evelyn, and Jendrassik-Grof methods use bili¬
rubin standards prepared in chloroform, methanol and human serum
respectively.
The Subcommittee on Bilirubin of the Standards Committee of the
American Association of Clinical Chemists defined an acceptable stand¬
ard (18).

They decreed that standards must be prepared in fresh human

serum, and that the standard must be treated in exactly the same man¬
ner as the sample whose bilirubin is to be measured.
Using the Malloy-Evelyn method, however, Meites and Traubert (15)
found that standards of bilirubin in chloroform-methanol gave the same
molar absorptivity as standards in aqueous serum solution, if correction
was made for the volume contraction of methanol-water solutions.
The Bower-Swale standardization employs chloroform solutions of
bilirubin, and also differs from the Subcommittee recommendations in
that the standards and the amniotic fluid are treated differently; the
reaction mixture contains acid buffer instead of amniotic fluid and
bilirubin in chloroform instead of pure chloroform.

17

Therefore the Jendrassik-Grof method is

the only one tested

that as published uses standards in conformity with Subconnittee
recommendations.

This writer used concentrated pooled human serum

albumin in the preparation of standards since
not available in sufficient quantities.
azobilirubin was within 0.7% of that
serum,

fresh human serum was

The molar absorptivity of

calculated by Gambino using

so that pooled human albumin is shown to be a convenient

ac¬

ceptable source of protein.
Fleming and Woolf developed their equation by measuring the
optical density of bilirubin standards in aqueous protein solutions,
and the molar absorptivity of bilirubin solutions
potentially inaccurate unless

are

recognized as

they are highly purified

(11) .

The methods studied in this paper gave varying results in meas¬
uring bilirubin;

the graphs

comparing AO.D. with bilirubin for the

Fleming-Woolf, Bower-Swale,

and Jendrassik-Grof methods were 0.59,

0.66,

and 0.74 respectively.

ferent

types

This may be a reflection of the dif¬

of standards used by each method as well as

coupling agents used for diazotization,

the different

since varying values

rubin determinations in serum using different methods

for bili¬

are will known

(23).
It is essential that

amniotic fluid bilirubin analyses be per¬

formed using a method which is accurate and repeatable by different
workers using differing equipment.
(Liley)

method is not suitable.

There is evidence that the AO.D.

While it is

optical density unit when all measurements

repeatable

to within 0.01

are made on the same spect¬

rophotometer, varying readings may be obtained when different instru¬
ments

are used.

Gambino

(10)

found that

the AO.D.

as determined by

-

'
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the

Cary

than

automatic

that

recording spectrophotometer is

obtained using the

suggested that

because

Beckman

the AO.D.

sults when performed by

DU Spectrophotometer.

method does not

different

laboratories,

essary

for each worker to determine his

values

for patient management.

determined,

ly

in

however,

order to

see

their own.

too

In

suitable

an

attempt

Conference

on Pediatric

reporting.

methods

tested in

replacing direct

found its

this

paper,

correlation with

obtained

a value

Of

of 0.74

The

spectrophotometer need not be

used,

the

of

0.024

the

it must

values

are not

of

is

and

to be

the

accumulated

direct spectrophotometry

determine

large

optical

density

and who wish

their own best

to use

straight

the

line

of

units.

recording

linear

quantities

0.99,

graph

at

type,

one wave¬

length.

Workers who have

most

Jendrassik-Grof had

continuous

only be

cooper¬

(Liley)

the

on

Such

This writer

slope

tested,

fur¬

gathered

Jendrassik-Grof

for the

standard error of estimate,

are

the AO.D.

the AO.D.

all methods

lowest

standards

if

(20)

findings.

spectrophotometry.

the

method may

mere¬

a larger series

Research

to pool their

laboratories

versus bilirubin.

and since

managed,

of management

deal statistically with

among the

and both have

AO.D.

Ross

to

deduce

however,

Gambino have

to be poorly

a method

to

meaningless,

for

values have been

few patients

may be

the

critical AO.D.

of erythroblastosis,

in erythroblastosis

Of

re¬

probably nec¬

involved in management

many workers

consistent

is

critical

fetuses would have

the

studies

it

Robertson

consistent

laboratory's

Until these

of patients,

ative

own

give

lower

obtain statistics.

Many workers

thermore,

many

consistently

of

data using

Jendrassik-Grof

comparing

the

.

;
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two methods

into mg.

and then

convert

per cent bilirubin,

the previously

with no

loss

of

obtained AO.D.

continuity

in

values

their

statistics.

With

bilirubin,

ment

consistent

and standardized

amniocentesis will be

of erythroblastosis.

techniques

still more

for measuring

useful in

the

manage¬

20
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